APA

Lieu C. H., Hidalgo M., Berlin J. D., Ko A. H., Cervantes A., LoRusso P., Gerber D. E., Eder J. P., Eckhardt S. G., Kapp A. V., Tsuhako A., McCall B., Pirzkall A., Uyei A. & Tabernero J. (20180521). A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS. : The oncologist.

Chicago

Lieu Christopher H, Hidalgo Manuel, Berlin Jordan D, Ko Andrew H, Cervantes Andres, LoRusso Patricia, Gerber David E, Eder J Paul, Eckhardt S Gail, Kapp Amy V, Tsuhako Amy, McCall Bruce, Pirzkall Andrea, Uyei Anne and Tabernero Josep. 20180521. A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS. : The oncologist.

Harvard

Lieu C. H., Hidalgo M., Berlin J. D., Ko A. H., Cervantes A., LoRusso P., Gerber D. E., Eder J. P., Eckhardt S. G., Kapp A. V., Tsuhako A., McCall B., Pirzkall A., Uyei A. and Tabernero J. (20180521). A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS. : The oncologist.

MLA

Lieu Christopher H, Hidalgo Manuel, Berlin Jordan D, Ko Andrew H, Cervantes Andres, LoRusso Patricia, Gerber David E, Eder J Paul, Eckhardt S Gail, Kapp Amy V, Tsuhako Amy, McCall Bruce, Pirzkall Andrea, Uyei Anne and Tabernero Josep. A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS. : The oncologist. 20180521.